Association between once- and twice-daily direct oral anticoagulant adherence in nonvalvular atrial fibrillation patients and rates of ischemic stroke

International Journal of Cardiology

Volumn 215, Issue , 2016, Pages 11-13

  Alberts, Mark J ^a   Peacock, W Frank ^b   Fields, Larry E ^c   Bunz, Thomas J ^d   Nguyen, Elaine ^d,e   Milentijevic, Dejan ^c   Schein, Jeff R ^c   Coleman, Craig I ^d,e  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^d UNIVERSITY OF CONNECTICUT   (United States)

^e HARTFORD HOSPITAL   (United States)

Author keywords

Anticoagulation; Direct oral anticoagulant; Medication adherence; Nonvalvular atrial fibrillation; Proportion of days covered

Indexed keywords

APIXABAN; DABIGATRAN; EDOXABAN; RIVAROXABAN; WARFARIN; ANTICOAGULANT AGENT;

ADULT; AGED; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY 29; ARTICLE; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CALCULATION; CARDIOVASCULAR DISEASE ASSESSMENT; CHA2DS2 SCORE; COHORT ANALYSIS; COMORBIDITY; COMORBIDITY ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HAS BLED SCORE; HOSPITAL PATIENT; HUMAN; ICD-9; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; NONVALVULAR ATRIAL FIBRILLATION; OUTPATIENT; PHARMACY QUALITY ALLIANCE; PRESCRIPTION; PRIORITY JOURNAL; PROPENSITY SCORE; VISUAL ANALOG SCALE; DRUG ADMINISTRATION; MEDICARE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; STATISTICS AND NUMERICAL DATA; STROKE; UNITED STATES; YOUNG ADULT;

ADMINISTRATION, ORAL; ADULT; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; DRUG ADMINISTRATION SCHEDULE; DRUG PRESCRIPTIONS; FEMALE; HUMANS; MALE; MEDICARE; MEDICATION ADHERENCE; MIDDLE AGED; PROPENSITY SCORE; STROKE; UNITED STATES; YOUNG ADULT;

EID: 84963935790     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.03.212     Document Type: Article

References (10)

1. H. Heidbuchel, P. Verhamme, M. Alings, M. Antz, W. Hacke, J. Oldgren, and et al. European Heart Rhythm Association. European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation Europace 15 2013 625 651
2. B. Vrijens, and H. Heidbuchel Non-vitamin K antagonist oral anticoagulants: considerations on once- vs. twice-daily regimens and their potential impact on medication adherence Europace 17 2015 514 523
3. W.L. Baker, and C.I. Coleman Medication adherence and non-vitamin K antagonist oral anticoagulants: what do we really know? Europace 17 2015 1316 1317
4. D.A. Lane, and G.Y. Lip Use of the CHA(2)DS(2)-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation Circulation 126 2012 860 865
5. P.C. Austin An introduction to propensity score methods for reducing the effects of confounding in observational studies Multivar. Behav. Res. 46 2011 399 424
6. A. Elixhauser, C. Steiner, D.R. Harris, and R.M. Coffey Comorbidity measures for use with administrative data Med. Care 36 1998 8 27
7. Nau DP. Proportion of Days Covered (PDC) as a Preferred Method of Measuring Medication Adherence. (Available at): http://www.pqaalliance.org/images/uploads/files/PQA%20PDC%20vs%20%20MPR.pdf (Last accessed on January 17, 2016).
8. D. Kubitza, S.C. Berkowitz, and F. Misselwitz Evidence-based evelopment and rationale for once-daily rivaroxaban dosing regimens across multiple indications Clin. Appl. Thromb. Hemost. 2016 10.1177/1076029616631427 (in press)
9. C.A. McHorney, C. Crivera, F. Laliberté, W.W. Nelson, G. Germain, B. Bookhart, and et al. Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure Curr. Med. Res. Opin. 31 2015 2167 2173
10. S. Shore, E.P. Carey, M.P. Turakhia, C.A. Jackevicius, F. Cunningham, L. Pilote, and et al. Adherence to dabigatran therapy and longitudinal patient outcomes: insights from the veterans health administration Am. Heart J. 167 2014 810 817